FDA Recommends DEA Move Cannabis to Schedule III


Newly released documents show that the US Food and Drug Administration (FDA) has declared cannabis to have legitimate medical use and advocates for its reclassification from Schedule I to Schedule III on controlled substances list. The 252-page report was sent to the US Drug Enforcement Administration (DEA) in August 2023, after being leaked to news outlet Bloomberg earlier the same year. Upon public release of the full report, the DEA is under pressure to act, although no set timeline exists. The DEA faces opposition from Republican members of Congress, whose letter stated “the known facts about marijuana have not changed since 2016”.

Source link

error: Content is protected !!